Natassia Tan, Natalie Ngu, Thomas Worland, Tanya Lee, Tobie Abrahams, Elliot Freeman, Nicholas Hannah, Kathryn Gazelakis, Richie G Madden, Kate D Lynch, Zina Valaydon, Siddharth Sood, Anouk Dev, Sally Bell, Alexander J Thompson, John Nik Ding, Amanda J Nicoll, Ken Liu, Keval Pandya, Paul Gow, John Lubel, William Kemp, Stuart K Roberts, Ammar Majeed
BACKGROUND: The benefits of regular surveillance imaging for cholangiocarcinoma in patients with primary sclerosing cholangitis (PSC) are unclear. Hence, we aimed to evaluate the impact of regular magnetic resonance cholangiopancreatography (MRCP) on outcomes of patients with PSC in Australia, where the practice of MRCP surveillance is variable. METHODS: The relationship between MRCP surveillance and survival outcomes was assessed in a multicenter, retrospective cohort of patients with PSC from 9 tertiary liver centers in Australia...
May 1, 2024: Hepatology Communications